GSK US news http://www.us-gsk.com/html/media-news/ GlaxoSmithKline is a leading healthcare company that helps people to do more, feel better and live longer. This RSS feed contains press releases and investor news. BREO™ ELLIPTA™ gains US approval for the treatment of COPD Fri, 10 May 2013 19:02:14 GMT http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1339369.htm http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1339369.htm GSK gives update on plans to share detailed clinical trial data as part of its commitment to transparency Tue, 07 May 2013 12:58:11 GMT http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1337754.htm http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1337754.htm Regulatory update: Trametinib US PDUFA date extended to 3 September 2013 Wed, 01 May 2013 11:54:07 GMT http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1335651.htm http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1335651.htm GSK announces regulatory submission for umeclidinium monotherapy in US Tue, 30 Apr 2013 12:15:11 GMT http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1335188.htm http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1335188.htm GlaxoSmithKline and Impax Pharmaceuticals terminate their collaboration on IPX066 Mon, 29 Apr 2013 12:12:46 GMT http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1334751.htm http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1334751.htm GSK and Theravance announce regulatory submission for ANORO™ ELLIPTA™ (UMEC/VI) in Japan Mon, 22 Apr 2013 09:10:39 GMT http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1332262.htm http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1332262.htm FDA Advisory Committee recommends approval of BREO(TM) ELLIPTA(TM) for the treatment of COPD Wed, 17 Apr 2013 19:39:34 GMT http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1330829.htm http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1330829.htm GlaxoSmithKline, Triangle Community Foundation Issue Call for Applications Totaling $400,000 in GSK IMPACT Awards Wed, 17 Apr 2013 15:00:00 GMT http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1330689.htm http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1330689.htm GlaxoSmithKline Issues Call for Applications Totaling $400,000 in GSK IMPACT Awards Wed, 17 Apr 2013 15:00:00 GMT http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1330664.htm http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1330664.htm GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive Fri, 05 Apr 2013 13:30:18 GMT http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1326694.htm http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1326694.htm GlaxoSmithKline announces start of phase III study of Benlysta® (belimumab ) in patients with vasculitis Wed, 03 Apr 2013 13:18:03 GMT http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1325603.htm http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1325603.htm Texas A&M System and GlaxoSmithKline receive U.S. Government approval to establish influenza vaccine facility in Texas Tue, 26 Mar 2013 14:06:36 GMT http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1323146.htm http://www.us-gsk.com/html/media-news/pressreleases/2013/2013-pressrelease-1323146.htm